Insider · CIK 0002009762
Kumar Budur
Files at HRMY (Harmony Biosciences Holdings, Inc.). First filing Sep 9, 2026, latest Sep 18, 2026.
Kumar Budur files SEC Form 4 as officer at HRMY (Harmony Biosciences Holdings, Inc.). Since Sep 9, 2026, Kumar Budur has reported 0 open-market buys worth $0 and 2 open-market sells worth $3.1M, the latest filed on Sep 18, 2026.
A track record needs three past buys with six months of prices behind them; Kumar Budur has 0, so none is measured yet.
The newest scored trade: sold $1.7M of HRMY on Sep 16, 2026, filed Sep 18, 2026, scored 25 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 2 sells worth $3.1M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
HRMY: Harmony Biosciences Holdings, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 25Weak | Harmony Biosciences Holdings, Inc. | $1.7M 38,452 shares | -258% | - | |
| 25Weak | Harmony Biosciences Holdings, Inc. | $1.5M 33,954 shares | -141% | - |
Transactions
Every row this insider has filed, 42 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Common Stock | +900 | $30.69 | $28k | 14,015 | 25 d ago |
| Sep 16, 2026 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Common Stock | +900 | $30.27 | $27k | 14,915 | 25 d ago |
| Sep 16, 2026 | HRMY Harmony Biosciences Holdings, Inc. | SOpen-market sale Common Stock10b5-1 | -1,800 | $43.01 | $77k | 13,115 | 25 d ago |
| Sep 17, 2026 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Common Stock | +400 | $30.69 | $12k | 13,515 | 25 d ago |
| Sep 17, 2026 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Common Stock | +400 | $30.27 | $12k | 13,915 | 25 d ago |
| Sep 17, 2026 | HRMY Harmony Biosciences Holdings, Inc. | SOpen-market sale Common Stock10b5-1 | -800 | $43.00 | $34k | 13,115 | 25 d ago |
| Sep 18, 2026 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Common Stock | +10,406 | $30.69 | $319k | 23,521 | 25 d ago |
| Sep 18, 2026 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Common Stock | +25,446 | $30.27 | $770k | 48,967 | 25 d ago |
| Sep 18, 2026 | HRMY Harmony Biosciences Holdings, Inc. | SOpen-market sale Common Stock10b5-1 | -35,852 | $43.05 | $1.5M | 13,115 | 25 d ago |
| Sep 16, 2026 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Stock Optionderivative | -900 | $0.00 | $0 | 29,400 | 25 d ago |
| Sep 16, 2026 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Stock Optionderivative | -900 | $0.00 | $0 | 63,346 | 25 d ago |
| Sep 17, 2026 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Stock Optionderivative | -400 | $0.00 | $0 | 29,000 | 25 d ago |
| Sep 17, 2026 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Stock Optionderivative | -400 | $0.00 | $0 | 62,946 | 25 d ago |
| Sep 18, 2026 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Stock Optionderivative | -10,406 | $0.00 | $0 | 18,594 | 25 d ago |
| Sep 18, 2026 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Stock Optionderivative | -25,446 | $0.00 | $0 | 37,500 | 25 d ago |
| Sep 4, 2026 | HRMY Harmony Biosciences Holdings, Inc. | SOpen-market sale Common Stock10b5-1 | -5,500 | $41.98 | $231k | 18,615 | 34 d ago |
| Sep 8, 2026 | HRMY Harmony Biosciences Holdings, Inc. | SOpen-market sale Common Stock10b5-1 | -4,500 | $42.25 | $190k | 14,115 | 34 d ago |
| Sep 8, 2026 | HRMY Harmony Biosciences Holdings, Inc. | SOpen-market sale Common Stock10b5-1 | -1,000 | $42.79 | $43k | 13,115 | 34 d ago |
| Sep 8, 2026 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Common Stock | +12,200 | $30.69 | $374k | 25,315 | 34 d ago |
| Sep 8, 2026 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Common Stock | +10,754 | $30.27 | $326k | 36,069 | 34 d ago |
| Sep 8, 2026 | HRMY Harmony Biosciences Holdings, Inc. | SOpen-market sale Common Stock10b5-1 | -22,954 | $43.10 | $989k | 13,115 | 34 d ago |
| Sep 8, 2026 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Stock Optionderivative | -12,200 | $0.00 | $0 | 30,300 | 34 d ago |
| Sep 8, 2026 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Stock Optionderivative | -10,754 | $0.00 | $0 | 64,246 | 34 d ago |
| May 1, 2026 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Common Stock | +18,750 | $0.00 | $0 | 32,997 | May 18, 2026 |
| May 1, 2026 | HRMY Harmony Biosciences Holdings, Inc. | FTax withholding Common Stock | -8,882 | $31.83 | $283k | 24,115 | May 18, 2026 |
| May 1, 2026 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -18,750 | $0.00 | $0 | 37,500 | May 18, 2026 |
| Jan 24, 2026 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Common Stock | +2,188 | $0.00 | $0 | 2,188 | Jan 26, 2026 |
| Jan 24, 2026 | HRMY Harmony Biosciences Holdings, Inc. | FTax withholding Common Stock | -1,153 | $36.82 | $42k | 1,035 | Jan 26, 2026 |
| Jan 25, 2026 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Common Stock | +2,662 | $0.00 | $0 | 2,662 | Jan 26, 2026 |
| Jan 25, 2026 | HRMY Harmony Biosciences Holdings, Inc. | FTax withholding Common Stock | -1,372 | $36.82 | $51k | 1,290 | Jan 26, 2026 |
| Jan 22, 2026 | HRMY Harmony Biosciences Holdings, Inc. | AGrant or award Stock Optionderivative | +42,600 | $0.00 | $0 | 42,600 | Jan 26, 2026 |
| Jan 22, 2026 | HRMY Harmony Biosciences Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +12,200 | $0.00 | $0 | 12,200 | Jan 26, 2026 |
| Jan 24, 2026 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -2,188 | $0.00 | $0 | 4,175 | Jan 26, 2026 |
| Jan 25, 2026 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -2,662 | $0.00 | $0 | 7,988 | Jan 26, 2026 |
| May 1, 2025 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Common Stock | +18,750 | $0.00 | $0 | 18,750 | May 9, 2025 |
| May 1, 2025 | HRMY Harmony Biosciences Holdings, Inc. | FTax withholding Common Stock | -8,869 | $29.86 | $265k | 9,881 | May 9, 2025 |
| May 1, 2025 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -18,750 | $0.00 | $0 | 18,750 | May 9, 2025 |
| Jan 24, 2025 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Common Stock | +2,187 | $0.00 | $0 | 2,187 | Jan 28, 2025 |
| Jan 24, 2025 | HRMY Harmony Biosciences Holdings, Inc. | FTax withholding Common Stock | -1,151 | $38.01 | $44k | 1,036 | Jan 28, 2025 |
| Jan 24, 2025 | HRMY Harmony Biosciences Holdings, Inc. | MOption exercise Restricted Stock Unitsderivative | -2,187 | $0.00 | $0 | 6,563 | Jan 28, 2025 |
| Jan 25, 2025 | HRMY Harmony Biosciences Holdings, Inc. | AGrant or award Stock Optionderivative | +37,400 | $0.00 | $0 | 37,400 | Jan 28, 2025 |
| Jan 25, 2025 | HRMY Harmony Biosciences Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +10,650 | $0.00 | $0 | 10,650 | Jan 28, 2025 |
Questions about Kumar Budur
Answered from the filings on this page, as of the latest one.
Is Kumar Budur buying or selling?
In the last 12 months Kumar Budur reported 0 open-market buys worth $0 and 2 open-market sells worth $3.1M on SEC Form 4; the latest was sold $1.7M of HRMY on Sep 16, 2026. Grants, option exercises and tax withholding are not counted.
How did Kumar Budur's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kumar Budur has 0.
Where does Kumar Budur file Form 4?
Kumar Budur has filed Form 4 at HRMY (Harmony Biosciences Holdings, Inc.) as CHIEF MEDICAL OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.